retatrutide nejm 2023 obesity trial ly3437943 Retatrutide Beat Semaglutide by 7.9% in Phase 2 — Here's the Trial Data Results from a new trial

Diet and exercise remain the foundation

Ozempic At-A-Glance GLP-1 is a hormone produced in the distal (lower) part of the small intestine in response to food intake

Avoid overcooking the vegetables

For many individuals this may be challenging, so supplementing with whole-foods sources of fiber, including apple pectin, oat fiber, beet fiber, carrot fiber and psyllium husk can help address gaps in dietary fiber intake

Strength Metabolic GLP-3 Retatrutide Retatrutide (LY3437943) is an investigational triple agonist at the GLP-1, GIP, and glucagon receptors, studied for metabolic research

Although clinical research exists, this product is research-use-only